First-generation FGS of HNSCC focused on the epidermal growth factor receptor (EGFR), based on its prominent expression in HNSCC and efficient in vivo detection of tumors and metastasis in preclinical studies13–15. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.